Cancer has taken an unrelenting toll on 72-year-old Mike Langford. After being diagnosed with non-Hodgkin lymphoma (NHL) in 2007 he suffered through five recurrences despite multiple rounds of chemotherapy and a stem cell transplant.
Many decades ago, my mother-in-law set an example I aim to follow: As an activist challenging certain government policies, she centered all her work on a foundational question: Is it good for the children?
A St. Louis jury on Wednesday heard opening statements in a new Roundup cancer trial that is the latest in a long line-up of coming courtroom battles over allegations that Monsanto’s popular weed killer causes cancer.
Earlier this month, a court decision about a chemical called glyphosate garnered headlines in newspapers across the country. And rightly so: glyphosate is the active ingredient in Monsanto’s Roundup weedkiller.
A Kansas City, Mo., jury on Thursday dismissed claims by a man who blamed his cancer on exposure to Monsanto’s Roundup herbicide, agreeing with the company that the weed killer was not the source of the man’s disease.
The U.S. Solicitor General on Tuesday dealt a blow to Monsanto owner Bayer AG, advising the U.S. Supreme Court that it should deny the company’s request for a review of a key Roundup cancer trial loss.
By Jon Heylings
From 1986 until 2008, I worked as the lead scientist on a project aimed at creating a “safer” paraquat-based weed killing product for what was then known as the ICI Central Toxicology Laboratory, which became part of Syngenta AG in 2000.
The California Office of Environmental Health Hazard Assessment (OEHHA) is proposing changes to its messaging to consumers regarding the cancer risk associated with products made with the weed killing chemical glyphosate.
EWG
Twitter
Instagram